cb-010,fludarabine,cyclophosphamide
Caribou Biosciences
['car-t']
$crbu 15% pm reports positive additional data from cb-010 allogeneic car-t cell therapy phase 1 antler trial at #eha22. 
Investor/trader focused primarily in the biopharma sector. 
Tweets are not investment advice and are not recommendations of any kind. @BTGPremium